Blackstone led a $200m funding round in DNAnexus, a developer of a biomedical informatics and data management platform, with participation from Northpond Ventures, GV, Perceptive Advisors, Innovatus Capital Partners, and Foresite Capital. “The funding enables us to accelerate our product roadmap to meet the global demand for technologies harnessing the power of biomedical data and driving precision medicine forward. Blackstone has shown a deep commitment to the healthcare, life sciences, and technology industries with a global network and operating resources. Blackstone will be a strong partner as we grow our business and support the new wave of biomedical insights generated by our customers using large-scale clinical, multi-omics data," Richard Daly, DNAnexus CEO.